Assessment of Neuroprotective Effects of Low-Intensity Transcranial Ultrasound Stimulation in a Parkinson’s Disease Rat Model by Fractional Anisotropy and Relaxation Time T2∗ Value

Assessment of Neuroprotective Effects of Low-Intensity Transcranial Ultrasound Stimulation in a Parkinson’s Disease Rat Model by Fractional Anisotropy and Relaxation Time T2∗ Value

Background: Low-intensity transcranial ultrasound (LITUS) may have a therapeutic effect on Parkinson’s disease (PD) patients to some extent. Fractional anisotropy (FA) and relaxation time T2∗ that indicate the integrity of fiber tracts and iron concentrations in brain tissue have been used to evalua...

Full description

Bibliographic Details
Main Authors:	Yanchao Dong, Defeng Liu, Yuemei Zhao, Yi Yuan, Wenxi Wang, Shuo Wu, Xin Liang, Zhanqiu Wang, Lanxiang Liu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-02-01
Series:	Frontiers in Neuroscience
Subjects:	Low-intensity transcranial ultrasound Parkinson’s disease magnetic resonance imaging diffusion tensor imaging substantia nigra neuroprotection
Online Access:	https://www.frontiersin.org/articles/10.3389/fnins.2021.590354/full

Similar Items

Transcranial sonography in Parkinson’s disease
by: I. V. Bayborodina, et al.
Published: (2018-03-01)

The L-type channel antagonist isradipine is neuroprotective in a mouse model of Parkinson's disease
by: E. Ilijic, et al.
Published: (2011-08-01)

Transcranial parenhymal sonography in the diagnosis of Parkinson's disease
by: Mijajlović Milija, et al.
Published: (2008-01-01)

Transcranial Sonographic Alterations of Substantia Nigra and Third Ventricle in Parkinson's Disease with or without Dementia
by: Zhi-Fen Dong, et al.
Published: (2017-01-01)

TRANSCRANIAL ULTRASONOGRAPHY IN PARKINSON’S DISEASE AND OTHER MOVEMENT DISORDERS
by: Nicoleta Tohanean, et al.
Published: (2009-12-01)

TRANSCRANIAL ULTRASONOGRAPHY IN PARKINSON’S DISEASE AND OTHER MOVEMENT DISORDERS
by: Nicoleta Tohanean, et al.
Published: (2009-09-01)

Specificity of transcranial sonography in parkinson spectrum disorders in comparison to degenerative cognitive syndromes
by: Laučkaitė Kristina, et al.
Published: (2012-03-01)

Impulsivity Relates to Relative Preservation of Mesolimbic Connectivity in Patients with Parkinson Disease
by: Hiro Sparks, et al.
Published: (2020-01-01)

Dietary and Intraperitoneal Administration of Selenium Provide Comparable Protection in the 6-Hydroxydopamine Lesion Rat Model of Parkinson's Disease
by: Cecilia M. Fox, et al.
Published: (2007-01-01)

The application value of quantitative susceptibility mapping in evaluating substantia nigra "swallow tail sign" in the diagnosis of Parkinson's disease
by: Xiao-jun GUAN, et al.
Published: (2018-04-01)

Chemical Exchange Saturation Transfer MRI Signal Loss of the Substantia Nigra as an Imaging Biomarker to Evaluate the Diagnosis and Severity of Parkinson's Disease
by: Chunmei Li, et al.
Published: (2017-08-01)

Analyzing the co-localization of substantia nigra hyper-echogenicities and iron accumulation in Parkinson's disease: A multi-modal atlas study with transcranial ultrasound and MRI
by: Seyed-Ahmad Ahmadi, et al.
Published: (2020-01-01)

Substantia Nigra Hyperechogenicity Reflects the Progression of Dopaminergic Neurodegeneration in 6-OHDA Rat Model of Parkinson’s Disease
by: Siyan Zhang, et al.
Published: (2020-08-01)

Preliminary Study of ADHD Biomarkers in Adults with Focus on Serum Iron and Transcranial Sonography of the Substantia Nigra
by: Geon-Ho Bahn, et al.
Published: (2021-05-01)

Amiloride is neuroprotective in an MPTP model of Parkinson's disease
by: Robert L. Arias, et al.
Published: (2008-09-01)

Differences in neural connectivity between the substantia nigra and ventral tegmental area in the human brain
by: Hyeok Gyu eKwon, et al.
Published: (2014-02-01)

Clinical features and dysfunctions of iron metabolism in Parkinson disease patients with hyper echogenicity in substantia nigra: a cross-sectional study
by: Shu-yang Yu, et al.
Published: (2018-01-01)

Neuroprotective effect of Lactobacillus plantarum DP189 on MPTP-induced Parkinson's disease model mice
by: Lei Wang, et al.
Published: (2021-10-01)

The Significance of Brain Transcranial Sonography in Burning Mouth Syndrome: a Pilot Study
by: Iris Zavoreo, et al.
Published: (2017-01-01)

Altered Tracer Distribution and Clearance in the Extracellular Space of the Substantia Nigra in a Rodent Model of Parkinson's Disease
by: Yuan Fang, et al.
Published: (2017-07-01)

Effects of Postnatal Enriched Environment in a Model of Parkinson’s Disease in Adult Rats
by: Adel Jungling, et al.
Published: (2017-02-01)

Mitochondrial DNA mutations in Parkinson's disease brain
by: David K. Simon, et al.
Published: (2017-04-01)

Cognitive performance patterns in healthy individuals with substantia nigra hyperechogenicity and early Parkinson’s disease
by: Rezzak Yilmaz, et al.
Published: (2016-11-01)

Detecting dopaminergic neuronal degeneration using diffusion tensor imaging in a rotenone-induced rat model of Parkinson's disease: fractional anisotropy and mean diffusivity values
by: Lan-xiang Liu, et al.
Published: (2017-01-01)

Chemical Exchange Saturation Transfer MR Imaging Is Superior to Diffusion Tensor Imaging in the Diagnosis and Severity Evaluation of Parkinson's Disease: a Study on Substantia Nigra and Striatum
by: Chunmei eLi, et al.
Published: (2015-10-01)

Diffusion Kurtosis Imaging for Detection of Early Brain Changes in Parkinson's Disease
by: Jitian Guan, et al.
Published: (2019-12-01)

Cortical thinning pattern according to differential nigrosome involvement in patients with Parkinson’s disease
by: Na-Young Shin, et al.
Published: (2020-01-01)

Diffusion Tensor Imaging in Parkinson's Disease and Parkinsonian Syndrome: A Systematic Review
by: Yu Zhang, et al.
Published: (2020-09-01)

Corrigendum: Diffusion Tensor Imaging in Parkinson's Disease and Parkinsonian Syndrome: A Systematic Review
by: Yu Zhang, et al.
Published: (2020-10-01)

Phase value assessment reveals iron accumulation in parkinson disease
by: Ayse Nur Sirin Ozcan, et al.
Published: (2020-09-01)

Substantia Nigra Radiomics Feature Extraction of Parkinson’s Disease Based on Magnitude Images of Susceptibility-Weighted Imaging
by: Qingguo Ren, et al.
Published: (2021-05-01)

The role of substantia nigra sonography in the differentiation of Parkinson’s disease and multiple system atrophy
by: Hai-Yan Zhou, et al.
Published: (2018-07-01)

Quantitative diffusion tensor imaging detects dopaminergic neuronal degeneration in a murine model of Parkinson’s disease
by: Michael D. Boska, et al.
Published: (2007-06-01)

Neuroprotective and Neurorescue Mode of Action of Bacopa monnieri (L.) Wettst in 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Induced Parkinson’s Disease: An In Silico and In Vivo Study
by: Babita Singh, et al.
Published: (2021-03-01)

Neuroprotective and Therapeutic Strategies against Parkinson’s Disease: Recent Perspectives
by: Sumit Sarkar, et al.
Published: (2016-06-01)

Utility of quantitative susceptibility mapping and diffusion kurtosis imaging in the diagnosis of early Parkinson’s disease
by: Samantha Tan, et al.
Published: (2021-01-01)

An early axonopathy in a hLRRK2(R1441G) transgenic model of Parkinson disease
by: Patricia Tagliaferro, et al.
Published: (2015-10-01)

Effect of potassium channel blocker Tetraethylammonium pretreatment on prevention of the 6-OHDA-induced chronic Parkinson's disease in rats
by: H. Haghdoost-Yazdi, et al.
Published: (2016-06-01)

Rationale and Design of the PAIRED Trial: Partnered Dance Aerobic Exercise as a Neuroprotective, Motor, and Cognitive Intervention in Parkinson's Disease
by: Madeleine E. Hackney, et al.
Published: (2020-10-01)

Regional High Iron in the Substantia Nigra Differentiates Parkinson’s Disease Patients From Healthy Controls
by: Kiarash Ghassaban, et al.
Published: (2019-05-01)